[PDF][PDF] Treat-to-target in systemic lupus erythematosus: where are we today
Clin Exp Rheumatol, 2012 - dial.uclouvain.be
Multiple clinical trials performed over twenty years in the treatment of rheumatoid arthritis
(RA) have clearly demonstrated that patients have better outcomes if their disease activity at …
(RA) have clearly demonstrated that patients have better outcomes if their disease activity at …
Treat-to-target in systemic lupus erythematosus: Where are we today?
M Mosca, D Boumpas, IN Bruce… - Clinical and …, 2012 - research.manchester.ac.uk
Multiple clinical trials performed over twenty years in the treatment of rheumatoid arthritis
(RA) have clearly demonstrated that patients have better outcomes if their disease activity at …
(RA) have clearly demonstrated that patients have better outcomes if their disease activity at …
Treat-to-target in systemic lupus erythematosus: where are we today?
M Mosca, DT Boumpas, IN Bruce… - Clinical and …, 2013 - research.regionh.dk
Multiple clinical trials performed over twenty years in the treatment of rheumatoid arthritis
(RA) have clearly demonstrated that patients have better outcomes if their disease activity at …
(RA) have clearly demonstrated that patients have better outcomes if their disease activity at …
Treat-to-target in systemic lupus erythematosus: where are we today?
M Mosca, DT Boumpas, IN Bruce… - Clinical and …, 2012 - dial.uclouvain.be
Multiple clinical trials performed over twenty years in the treatment of rheumatoid arthritis
(RA) have clearly demonstrated that patients have better outcomes if their disease activity at …
(RA) have clearly demonstrated that patients have better outcomes if their disease activity at …
Treat-to-target in systemic lupus erythematosus: where are we today?
M Mosca, DT Boumpas, IN Bruce… - Clinical and …, 2012 - europepmc.org
Multiple clinical trials performed over twenty years in the treatment of rheumatoid arthritis
(RA) have clearly demonstrated that patients have better outcomes if their disease activity at …
(RA) have clearly demonstrated that patients have better outcomes if their disease activity at …
Treat-to-target in systemic lupus erythematosus: where are we today?
M Mosca, DT Boumpas… - Clinical and …, 2012 - researchinformation.amsterdamumc …
Multiple clinical trials performed over twenty years in the treatment of rheumatoid arthritis
(RA) have clearly demonstrated that patients have better outcomes if their disease activity at …
(RA) have clearly demonstrated that patients have better outcomes if their disease activity at …
Treat-to-target in systemic lupus erythematosus: where are we today?
M Mosca, DT Boumpas, IN Bruce, R Cervera… - 0392 …, 2012 - escholar.manchester.ac.uk
Multiple clinical trials performed over twenty years in the treatment of rheumatoid arthritis
(RA) have clearly demonstrated that patients have better outcomes if their disease activity at …
(RA) have clearly demonstrated that patients have better outcomes if their disease activity at …
[引用][C] Treat-to-target in systemic lupus erythematosus: where are we today?
M Mosca, D Boumpas, I Bruce, R Cervera… - CLINICAL AND …, 2012 - arpi.unipi.it
Treat-to-target in systemic lupus erythematosus: where are we today? IRIS IRIS Home Sfoglia
Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano Italiano English English LOGIN …
Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano Italiano English English LOGIN …
[PDF][PDF] Treat-to-target in systemic lupus erythematosus: where are we today?
M Mosca, D Boumpas, IN Bruce, R Cervera… - Clin Exp …, 2012 - clinexprheumatol.org
Multiple clinical trials performed over twenty years in the treatment of rheumatoid arthritis
(RA) have clearly demonstrated that patients have better outcomes if their disease activity at …
(RA) have clearly demonstrated that patients have better outcomes if their disease activity at …
Treat-to-target in systemic lupus erythematosus: where are we today?
M Mosca, DT Boumpas, IN Bruce… - Clinical and …, 2012 - pubmed.ncbi.nlm.nih.gov
Multiple clinical trials performed over twenty years in the treatment of rheumatoid arthritis
(RA) have clearly demonstrated that patients have better outcomes if their disease activity at …
(RA) have clearly demonstrated that patients have better outcomes if their disease activity at …